Showing all posts written by Mark Speegle

Mark Speegle
Mark Speegle
Mark Speegle is an associate in our Orange County office. He specializes in intellectual property law, and has worked on both patent prosecution and patent litigation issues in a variety of fields including optics, semiconductors, medical devices, and software. Mr. Speegle received a Bachelor’s Degree in Physics with a minor in Political Science from the University of Southern California. Mr. Speegle received his J.D. from the University of Texas School of Law where he was on the Texas Intellectual Property Law Journal, and was a member of the Intellectual Property Society.

Mr. Speegle worked as a summer associate at the firm in 2012 and joined the firm in 2013.
Click here to read full bio

Ethicon To Acquire Torax Medical, Inc.

Ethicon Inc. announced on February 17 that it reached an agreement to acquire Torax Medical, Inc.  According to its website, Torax Medical is a privately held medical device company developing a minimally invasive surgical treatment

InSeal's InClosure VCD, before and after biodegredation.

InSeal Medical Receives CE Mark for Vascular Closure Device

InSeal Medical recently announced that it has received CE Mark approval for its InClosure large bore vascular closure device (VCD).  The InSeal VCD provides an internal biodegradable membrane for sealing large cuts in blood vessels. 

HeartWare Cancels $930M Deal with Valtech Cardio

HeartWare International, Inc. has announced that it will not longer proceed with its previously announced deal to acquire Valtech Cardio, Ltd.  Valtech is a privately held Israeli company developing transcatheter mitral and tricuspid

HeartWare International To Acquire Valtech Cardio

HeartWare International recently announced that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd.  Yehuda, Israe-based Valtech Cardio currently provides a transcatheter mitral valve repair product 

VertiFlex Announces FDA Approval of Superion Interspinous Spacer System

By: Mark Speegle

(May 26, 2015) VertiFlex, Inc., announced that it has been granted pre-market approval by the FDA for its minimally invasive treatment of lumbar spinal stenosis, the Superion Interspinous Spacer System.  This approval

FDA Approves Expanded Use of Medtronic’s CoreValve System; Also Receives Regulatory Approval in Japan

This week the U.S. Food and Drug Administration announced its approval of Medtronic’s CoreValve system for “valve-in-valve” (VIV) replacement. According to the FDA press release, this represents the first transcatheter

DePuy Synthes Announces Acquisition of Olive Medical

By: Mark Speegle

(Feb. 11, 2015)  DePuy Synthes, a Johnson & Johnson company, announced its acquisition of Olive Medical Corporation in a press release.  The financial terms of the deal were not disclosed.  According to its website, 

California Healthcare Institute Releases 2015 California Biomedical Industry Report

By Mark Speegle

(Nov. 20, 2014)  The California Healthcare Institute and PricewaterhouseCoopers, LLP have released their 2015 California Biomedical Industry Report describing industry trends through 2014.  The CHI report highlights